Treosulfan is used both as monotherapy (if there are contraindications to the use of cisplatin) and in combination with cisplatin or other antitumor drugs for the palliative treatment of stage II-IV epithelial ovarian tumors.
Active ingredient: treosulfan
Prescription medicine